Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 7 Similar Profiles
Tuberculosis Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Rifampin Medicine & Life Sciences
HIV Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
Safety Medicine & Life Sciences
Multidrug-Resistant Tuberculosis Medicine & Life Sciences
Area Under Curve Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2017

Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials

Savic, R. M., Weiner, M., Mackenzie, W. R., Engle, M., Whitworth, W. C., Johnson, J. L., Nsubuga, P., Nahid, P., Nguyen, N. V., Peloquin, C. A., Dooley, K. E. & Dorman, S. E. 2017 In : Clinical Pharmacology and Therapeutics.

Research output: Contribution to journalArticle

Phase II Clinical Trials
Pulmonary Tuberculoses
Pharmacokinetics
Lung
Rifampin

Importance of Drug Pharmacokinetics at the Site of Action

Rizk, M. L., Zou, L., Savic, R. M. & Dooley, K. E. May 1 2017 In : Clinical and Translational Science. 10, 3, p. 133-142 10 p.

Research output: Contribution to journalReview article

Pharmacokinetics

In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis

Kaushik, A., Ammerman, N. C., Tasneen, R., Story-Roller, E., Dooley, K. E., Dorman, S. E., Nuermberger, E. L. & Lamichhane, G. Aug 1 2017 In : Journal of Antimicrobial Chemotherapy. 72, 8, p. 2320-2325 6 p., dkx152

Research output: Contribution to journalArticle

Rifampin
Mycobacterium tuberculosis
In Vitro Techniques
Carbapenems
Drug Therapy

New Paradigm for Translational Modeling to Predict Long-term Tuberculosis Treatment Response

Bartelink, I. H., Zhang, N., Keizer, R. J., Strydom, N., Converse, P. J., Dooley, K. E., Nuermberger, E. L. & Savic, R. M. 2017 In : Clinical and Translational Science.

Research output: Contribution to journalArticle

Tuberculosis
Confidence Intervals
Anthralin
Rifampin
Pharmacokinetics

Pediatric multidrug-resistant tuberculosis clinical trials: challenges and opportunities

McAnaw, S. E., Hesseling, A. C., Seddon, J. A., Dooley, K. E., Garcia-Prats, A. J., Kim, S., Jenkins, H. E., Schaaf, H. S., Sterling, T. R. & Horsburgh, C. R. Mar 1 2017 In : International Journal of Infectious Diseases. 56, p. 194-199 6 p.

Research output: Contribution to journalReview article

Multidrug-Resistant Tuberculosis
Clinical Trials
Pediatrics
Tuberculosis
Pharmacokinetics